Matrix metalloproteinase and tumor necrosis factor inhibitors

Details Matrix metalloproteinase and tumor necrosis factor inhibitors Matrix metalloproteinase and tumor necrosis factor inhibitors

A - Human Necessities

61

K

A61K 31/506 (2006.01) A61K 31/70 (2006.01)

Patent

CA 2419773

The invention discloses methods of treatment and prevention for TNF.alpha.- related disorders and MMP-related disorders and compounds useful in such treatments. In particular, the invention dislcoses pharmaceutical compositions comprising a compound of the general formula. (see fig I) wherein X is a Zn(II) chelating group and selected from the group consisting of (CH2)n OH, (CH2)n NH2, (CH2)n SH, (CH2)m COOH, (CH2)m COOR, (CH2)m CONH2, (CH2)m''CONH-OH, (CH2)m''CONH-R, and (CH2)n~O(PO3)m''(m''+ l), wherein n=2, 3, 4, or 5, n'=2 or 3, m=1, 2, 3, or 4, m'=1, 2, 3, 4, 5, or 6, m"=1, 2, 3, and R = - C m-H2m'+ l or aryl groups, especially ~-[3,4-dihydroxy-5-(2-hydroxyethyl)- tetrahydrofuran-2-yl]pyrimidine-2,4(1H,3H)-dione, which has an inhibitory effect on matrix metalloproteinase-2 (gelatinase A) and on the binding of TNF.alpha. to TNF.alpha.-RI.

Affiliated with

Also associated with

Rating

Matrix metalloproteinase and tumor necrosis factor inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Matrix metalloproteinase and tumor necrosis factor inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Matrix metalloproteinase and tumor necrosis factor inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1779081